CoChat

The NF-Y/p53 liaison: Well beyond repression

Open access
Imbriano, Carol, Gnesutta, Nerina, Mantovani, Roberto · 2012 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Cited by 38

The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.

Abstract

NF-Y is a sequence-specific transcription factor - TF - targeting the common CCAAT promoter element. p53 is a master TF controlling the response to stress signals endangering genome integrity, often mutated in human cancers. The NF-Y/p53 - and p63, p73 - interaction results in transcriptional repression of a subset of genes within the vast NF-Y regulome under DNA-damage conditions. Recent data shows that NF-Y is also involved in pro-apoptotic activities, either directly, by mediating p53 transcriptional activation, or indirectly, by being targeted by a non coding RNA, PANDA. The picture is subverted in cells carrying Gain-of-function mutant p53, through interactions with TopBP1, a protein also involved in DNA repair and replication. In summary, the connection between p53 and NF-Y is crucial in determining cell survival or death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.bbcan.2011.11.001

Cites

18 of 18 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 118

  1. Vousden, 2002, Activation of the p53 tumor suppressor protein, Biochim. Biophys. Acta, 1602, 47
  2. Dolfini, 2009, A perspective of promoter architecture from the CCAAT box, Cell Cycle, 8, 4127, 10.4161/cc.8.24.10240 · DOI
  3. Romier, 2003, The NF-YB/NF-YC structure gives insight into DNA binding and transcription regulation by CCAAT factor NF-Y, J. Biol. Chem., 278, 1336, 10.1074/jbc.M209635200 · DOI · Paper page
  4. Kamada, 2001, Crystal structure of negative cofactor 2 recognizing the TBP-DNA transcription complex, Cell, 106, 71, 10.1016/S0092-8674(01)00417-2 · DOI · Paper page
  5. Poot, 2000, HuCHRAC, a human ISWI chromatin remodelling complex contains hACF1 and two novel histone-fold proteins, EMBO J., 19, 3377, 10.1093/emboj/19.13.3377 · DOI · Paper page
  6. Li, 2000, Identification and cloning of two histone fold motif-containing subunits of HeLa DNA polymerase epsilon, J. Biol. Chem., 275, 23247, 10.1074/jbc.M002548200 · DOI · Paper page
  7. Bolognese, 2000, Cloning and characterization of the histone-fold proteins YBL1 and YCL1, Nucleic Acids Res., 28, 3830, 10.1093/nar/28.19.3830 · doi:10.1093/nar/28.19.3830
  8. Vousden, 2002, Live or let die: the cell's response to p53, Nat Rev Cancer, 2, 594, 10.1038/nrc864 · DOI · Paper page
  9. Funk, 1992, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol. Cell. Biol., 12, 2866, 10.1128/MCB.12.6.2866 · DOI · Paper page
  10. Bourdon, 1997, Further characterisation of the p53 responsive element—identification of new candidate genes for trans-activation by p53, Oncogene, 14, 85, 10.1038/sj.onc.1200804 · DOI
  11. el-Deiry, 1998, Regulation of p53 downstream genes, Semin. Cancer Biol., 8, 345, 10.1006/scbi.1998.0097 · DOI · Paper page
  12. Ko, 1996, p53: puzzle and paradigm, Genes Dev., 10, 1054, 10.1101/gad.10.9.1054 · DOI · Paper page
  13. Willis, 2002, The promise and obstacle of p53 as a cancer therapeutic agent, Curr. Mol. Med., 2, 329, 10.2174/1566524023362474 · DOI
  14. Ceribelli, 2008, The histone-like NF-Y is a bifunctional transcription factor, Mol. Cell. Biol., 28, 2047, 10.1128/MCB.01861-07 · DOI
  15. Böhlig, 2011, One function—multiple mechanisms: the manifold activities of p53 as a transcriptional repressor, J. Biomed. Biotechnol., 2011, 464916, 10.1155/2011/464916 · DOI · Paper page
  16. Wang, 2010, The p53 response element and transcriptional repression, Cell Cycle, 9, 870, 10.4161/cc.9.5.10825 · DOI · Paper page
  17. Zhao, 2000, Analysis of p53-regulated gene expression patterns using oligonucleotide arrays, Genes Dev., 14, 981, 10.1101/gad.14.8.981 · DOI · Paper page
  18. Murphy, 1996, Wild-type p53 negatively regulates the expression of a microtubule-associated protein, Genes Dev., 10, 2971, 10.1101/gad.10.23.2971 · DOI · Paper page
  19. Tokino, 1994, p53 tagged sites from human genomic DNA, Hum. Mol. Genet., 3, 1537, 10.1093/hmg/3.9.1537 · DOI · Paper page
  20. Johnson, 2001, Transcriptional repression by p53 through direct binding to a novel DNA element, J. Biol. Chem., 276, 27716, 10.1074/jbc.C100121200 · DOI · Paper page
  21. Hoffman, 2002, Transcriptional repression of the anti-apoptotic survivin gene by wild type p53, J. Biol. Chem., 277, 3247, 10.1074/jbc.M106643200 · DOI · Paper page
  22. Wang, 2009, Redefining the p53 response element, Proc. Natl. Acad. Sci. U. S. A., 106, 14373, 10.1073/pnas.0903284106 · DOI · Paper page
  23. Wang, 2009, LIM and SH3 protein 1 (Lasp1) is a novel p53 transcriptional target involved in hepatocellular carcinoma, J. Hepatol., 50, 528, 10.1016/j.jhep.2008.10.025 · DOI
  24. D'Souza, 2001, The gene encoding p202, an interferon-inducible negative regulator of the p53 tumor suppressor, is a target of p53-mediated transcriptional repression, J. Biol. Chem., 276, 298, 10.1074/jbc.M007155200 · DOI
  25. Kho, 2004, p53-regulated transcriptional program associated with genotoxic stress-induced apoptosis, J. Biol. Chem., 279, 21183, 10.1074/jbc.M311912200 · DOI · Paper page
  26. Arias-Lopez, 2006, p53 modulates homologous recombination by transcriptional regulation of the RAD51 gene, EMBO Rep., 7, 219, 10.1038/sj.embor.7400587 · DOI · Paper page
  27. Hsieh, 2008, Human DDA3 is an oncoprotein down-regulated by p53 and DNA damage, Biochem. Biophys. Res. Commun., 369, 567, 10.1016/j.bbrc.2008.02.047 · DOI
  28. Zhang, 2004, Repression of hsp90beta gene by p53 in UV irradiation-induced apoptosis of Jurkat cells, J. Biol. Chem., 279, 42545, 10.1074/jbc.M314213200 · DOI · Paper page
  29. Li, 2004, Identification of PRC1 as the p53 target gene uncovers a novel function of p53 in the regulation of cytokinesis, Oncogene, 23, 9336, 10.1038/sj.onc.1208114 · DOI
  30. van Bodegom, 2010, Mechanisms of p53-mediated repression of the human polycystic kidney disease-1 promoter, Biochim. Biophys. Acta, 1799, 502, 10.1016/j.bbagrm.2010.04.001 · DOI
  31. Taylor, 2001, Regulation of the G2/M transition by p53, Oncogene, 20, 1803, 10.1038/sj.onc.1204252 · DOI · Paper page
  32. de Toledo, 1998, Regulation by ionizing radiation of CDC2, cyclin A, cyclin B, thymidine kinase, topoisomerase IIalpha, and RAD51 expression in normal human diploid fibroblasts is dependent on p53/p21Waf1, Cell Growth Differ, 9, 887
  33. Yun, 1999, p53 negatively regulates cdc2 transcription via the CCAATbinding NF-Y transcription factor, J. Biol. Chem., 274, 29677, 10.1074/jbc.274.42.29677 · DOI · Paper page
  34. Innocente, 1999, p53 regulates a G2 checkpoint through cyclin B1, Proc. Natl. Acad. Sci. U. S. A., 96, 2147, 10.1073/pnas.96.5.2147 · DOI · Paper page
  35. Taylor, 1999, Mechanisms of G2 arrest in response to overexpression of p53, Mol. Biol. Cell, 10, 3607, 10.1091/mbc.10.11.3607 · DOI · Paper page
  36. Krause, 2000, The tumour suppressor protein p53 can repress transcription of cyclin B, Nucleic Acids Res., 28, 4410, 10.1093/nar/28.22.4410 · DOI · Paper page
  37. Krause, 2001, Expression of the cell cycle phosphatase cdc25C is down-regulated by the tumour suppressor protein p53 but not by p73, Biochem. Biophys. Res. Commun., 284, 743, 10.1006/bbrc.2001.5040 · DOI
  38. Manni, 2001, NF-Y mediates the transcriptional inhibition of the cyclin B1, cyclin B2, and cdc25C promoters upon induced G2 arrest, J. Biol. Chem., 276, 5570, 10.1074/jbc.M006052200 · DOI · Paper page
  39. Badie, 2000, Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G(2)/M arrest in human cells, Mol. Cell. Biol., 20, 2358, 10.1128/MCB.20.7.2358-2366.2000 · DOI · Paper page
  40. Zhu, 2002, Identification of promoter elements responsible for transcriptional inhibition of polo-like kinase 1 and topoisomerase IIalpha genes by p21(WAF1/CIP1/SDI1), Cell Cycle, 1, 59, 10.4161/cc.1.1.101 · DOI · Paper page
  41. St Clair, 2004, DNA damage-induced downregulation of Cdc25C is mediated by p53 via two independent mechanisms: one involves direct binding to the cdc25C promoter, Mol. Cell, 16, 725, 10.1016/j.molcel.2004.11.002 · DOI · Paper page
  42. Matsui, 2004, Negative regulation of Chk2 expression by p53 is dependent on the CCAAT-binding transcription factor NF-Y, J. Biol. Chem., 279, 25093, 10.1074/jbc.M403232200 · DOI · Paper page
  43. Imbriano, 2005, Direct p53 transcriptional repression: in vivo analysis of CCAAT-containing G2/M promoters, Mol. Cell. Biol., 25, 3737, 10.1128/MCB.25.9.3737-3751.2005 · DOI · Paper page
  44. Basile, 2006, DNA damage promotes histone deacetylase 4 nuclear localization and repression of G2/M promoters, via p53 C-terminal lysines, J. Biol. Chem., 281, 2347, 10.1074/jbc.M507712200 · DOI
  45. Scian, 2008, Wild-type p53 and p73 negatively regulate expression of proliferation related genes, Oncogene, 27, 2583, 10.1038/sj.onc.1210898 · DOI
  46. St Clair, 2006, The dual specificity phosphatase Cdc25C is a direct target for transcriptional repression by the tumor suppressor p53, Cell Cycle, 5, 709, 10.4161/cc.5.7.2628 · DOI
  47. Kaeser, 2002, Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo, Proc. Natl. Acad. Sci. U. S. A., 99, 95, 10.1073/pnas.012283399 · DOI · Paper page
  48. Ceribelli, 2006, Repression of new p53 targets revealed by ChIP on chip experiments, Cell Cycle, 5, 1102, 10.4161/cc.5.10.2777 · DOI · Paper page
  49. Shaked, 2008, Chromatin immunoprecipitation-on-chip reveals stress-dependent p53 occupancy in primary normal cells but not in established cell lines, Cancer Res., 68, 9671, 10.1158/0008-5472.CAN-08-0865 · DOI · Paper page
  50. Elkon, 2003, Genome-wide in silico identification of transcriptional regulators controlling the cell cycle in human cells, Genome Res., 13, 773, 10.1101/gr.947203 · DOI · Paper page
  51. Linhart, 2005, Deciphering transcriptional regulatory elements that encode specific cell cycle phasing by comparative genomics analysis, Cell Cycle, 4, 1788, 10.4161/cc.4.12.2173 · DOI · Paper page
  52. Halperin, 2009, Allegro: analyzing expression and sequence in concert to discover regulatory programs, Nucleic Acids Res., 37, 1566, 10.1093/nar/gkn1064 · DOI
  53. McKenzie, 2010, p53-dependent repression of polo-like kinase-1, Cell Cycle, 15, 4200, 10.4161/cc.9.20.13532 · DOI · Paper page
  54. Banerjee, 2009, DNA damage induced p53 downregulates Cdc20 by direct binding to its promoter causing chromatin remodeling, Nucleic Acids Res., 37, 2688, 10.1093/nar/gkp110 · DOI · Paper page
  55. Yang, 2008, Kinetics of repression by modified p53 on the PDGF beta-receptor promoter, Int. J. Cancer, 123, 2020, 10.1002/ijc.23735 · DOI
  56. Yun, 2003, Cdk2-dependent phosphorylation of the NF-Y transcription factor and its involvement in the p53-p21 signaling pathway, J Biol Chem, 278, 36966, 10.1074/jbc.M305178200 · DOI · Paper page
  57. Chae, 2004, Cdk2-dependent phosphorylation of the NF-Y transcription factor is essential for the expression of the cell cycle-regulatory genes and cell cycle G1/S and G2/M transitions, Oncogene, 23, 4084, 10.1038/sj.onc.1207482 · DOI
  58. Yun, 2006, p53 prevents immature escaping from cell cycle G2 checkpoint arrest through inhibiting cdk2-dependent NF-Y phosphorylation, Cancer Res Treat, 38, 224, 10.4143/crt.2006.38.4.224 · DOI
  59. Jin, 1998, Transcriptional regulation of the MDR1 gene by histone acetyltransferase and deacetylase is mediated by NF-Y, Mol. Cell. Biol., 18, 4377, 10.1128/MCB.18.7.4377 · DOI · Paper page
  60. Peng, 2007, Irradiation modulates association of NF-Y with histone-modifying cofactors PCAF and HDAC, Oncogene, 26, 7576, 10.1038/sj.onc.1210565 · doi:10.1038/sj.onc.1210565
  61. Kato, 2009, Characterization of the HDAC1 complex that regulates the sensitivity of cancer cells to oxidative stress, Cancer Res., 69, 3597, 10.1158/0008-5472.CAN-08-4368 · DOI
  62. Rinn, 2011, To repress or not to repress: this is the guardian's question, Trends Cell Biol., 21, 344, 10.1016/j.tcb.2011.04.002 · DOI
  63. Godar, 2008, Growth-inhibitory and tumor-suppressive functions of p53 depend on its repression of CD44 expression, Cell, 134, 62, 10.1016/j.cell.2008.06.006 · DOI · Paper page
  64. Li, 1998, Xenopus NF-Y pre-sets chromatin to potentiate p300 and acetylation-responsive transcription from the Xenopus hsp70 promoter in vivo, EMBO J., 17, 6300, 10.1093/emboj/17.21.6300 · DOI · Paper page
  65. Wu, 2005, DeltaNp63alpha up-regulates the Hsp70 gene in human cancer, Cancer Res., 65, 758, 10.1158/0008-5472.758.65.3 · DOI
  66. Xu, 2001, Transcriptional activity of the SHP-1 gene in MCF7 cells is differentially regulated by binding of NF-Y factor to two distinct CCAAT-elements, Gene, 269, 141, 10.1016/S0378-1119(01)00445-0 · DOI
  67. Montano, 2009, Repression of SHP-1 expression by p53 leads to trkA tyrosine phosphorylation and suppression of breast cancer cell proliferation, Oncogene, 28, 3787, 10.1038/onc.2009.143 · DOI
  68. Clem, 2003, Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells, Gene, 322, 113, 10.1016/j.gene.2003.08.012 · doi:10.1016/j.gene.2003.08.012
  69. Gatta, 2008, NF-Y substitutes H2A-H2B on active cell-cycle promoters: recruitment of CoREST-KDM1 and fine-tuning of H3 methylations, Nucleic Acids Res., 36, 6592, 10.1093/nar/gkn699 · DOI
  70. Benlhabib, 2006, Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y, Gene, 377, 177, 10.1016/j.gene.2006.04.004 · doi:10.1016/j.gene.2006.04.004
  71. Fung, 2001, Key role of a downstream specificity protein 1 site in cell cycle-regulated transcription of the AP endonuclease gene APE1/APEX in NIH3T3 cells, J. Biol. Chem., 276, 42011, 10.1074/jbc.M106423200 · DOI
  72. Fan, 2002, BRCA1 regulates GADD45 through its interactions with the OCT-1 and CAAT motifs, J. Biol. Chem., 277, 8061, 10.1074/jbc.M110225200 · DOI
  73. Coustry, 2001, CBF/NF-Y functions both in nucleosomal disruption and transcription activation of the chromatin-assembled topoisomerase IIalpha promoter. Transcription activation by CBF/NF-Y in chromatin is dependent on the promoter structure, J. Biol. Chem., 276, 40621, 10.1074/jbc.M106918200 · DOI
  74. Pesce, 1999, Interaction between the (−170) CRE and the (−150) CCAAT box is necessaryfor efficient activation of the fibronectin gene promoter by cAMP and ATF-2, FEBS Lett., 457, 445, 10.1016/S0014-5793(99)01091-1 · DOI
  75. Alonso, 1996, The CCAAT-binding proteins CP1 and NF-I cooperate with ATF-2 in the transcription of the fibronectin gene, J. Biol. Chem., 271, 22271, 10.1074/jbc.271.36.22271 · DOI
  76. Ratovitski, 2010, LKB1/PEA3/ΔNp63 pathway regulates PTGS-2 (COX-2) transcription in lung cancer cells upon cigarette smoke exposure, Oxid. Med. Cell. Longev., 3, 317, 10.4161/oxim.3.5.13108 · DOI
  77. Faniello, 2008, p53-mediated downregulation of H ferritin promoter transcriptional efficiency via NF-Y, Int. J. Biochem. Cell Biol., 40, 2110, 10.1016/j.biocel.2008.02.010 · DOI · Paper page
  78. Zhou, 2003, DNA damage-induced inhibition of securin expression is mediated by p53, J. Biol. Chem., 278, 462, 10.1074/jbc.M203793200 · DOI
  79. Rother, 2007, p53 downregulates expression of the G(1)/S cell cycle phosphatase Cdc25A, Oncogene, 26, 1949, 10.1038/sj.onc.1209989 · DOI
  80. Rother, 2007, Gene expression of cyclin-dependent kinase subunit Cks2 is repressed by the tumor suppressor p53 but not by the related proteins p63 or p73, FEBS Lett., 581, 1166, 10.1016/j.febslet.2007.02.028 · DOI
  81. Rother, 2007, Expression of cyclin-dependent kinase subunit 1 (Cks1) is regulated during the cell cycle by a CDE/CHR tandem element and is downregulated by p53 but not by p63 or p73, Cell Cycle, 6, 853, 10.4161/cc.6.7.4017 · DOI
  82. Barsotti, 2009, Pro-proliferative FoxM1 is a target of p53-mediated repression, Oncogene, 28, 4295, 10.1038/onc.2009.282 · DOI · Paper page
  83. Gaub, 1990, Activation of the ovalbumin gene by the estrogen receptor involves the fos–jun complex, Cell, 63, 1267, 10.1016/0092-8674(90)90422-B · DOI · Paper page
  84. Dalvai, 2011, Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors, Oncogene, 30, 2282, 10.1038/onc.2010.588 · DOI
  85. van der Watt, 2011, The nuclear exporter, Crm1, is regulated by NFY and Sp1 in cancer cells and repressed by p53 in response to DNA damage, Biochim. Biophys. Acta, 1809, 316, 10.1016/j.bbagrm.2011.05.017 · DOI
  86. Hirose, 2003, p53-independent induction of Gadd45 by histone deacetylase inhibitor: coordinate regulation by transcription factors Oct-1 and NF-Y, Oncogene, 22, 7762, 10.1038/sj.onc.1207091 · DOI
  87. Izumi, 2001, Mechanism for the transcriptional repression by c-Myc on PDGF beta-receptor, J. Cell Sci., 114, 1533, 10.1242/jcs.114.8.1533 · DOI · Paper page
  88. Mao, 2004, Promoter-binding and repression of PDGFRB by c-Myc are separable activities, Nucleic Acids Res., 32, 3462, 10.1093/nar/gkh669 · DOI
  89. Müller, 2010, The central role of CDE/CHR promoter elements in the regulation of cell cycle-dependent gene transcription, FEBS J., 277, 877, 10.1111/j.1742-4658.2009.07508.x · DOI · Paper page
  90. Jung, 2001, p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor, Oncogene, 20, 5818, 10.1038/sj.onc.1204748 · DOI
  91. Hackzell, 2002, p73 independent of c-Myc represses transcription of platelet-derived growth factor beta-receptor through interaction with NF-Y, J. Biol. Chem., 277, 39769, 10.1074/jbc.M204483200 · DOI
  92. Testoni, 2006, Mechanisms of transcriptional repression of cell-cycle G2/M promoters by p63, Nucleic Acids Res., 34, 928, 10.1093/nar/gkj477 · DOI
  93. Uramoto, 2004, p73 competes with co-activators and recruits histone deacetylase to NF-Y in the repression of PDGF beta-receptor, J. Cell Sci., 117, 5323, 10.1242/jcs.01384 · doi:10.1242/jcs.01384
  94. Liberati, 2001, Cooperation and competition between the binding of COUP-TFII and NF-Y on human epsilon- and gamma-globin gene promoters, J. Biol. Chem., 276, 41700, 10.1074/jbc.M102987200 · DOI
  95. Liberati, 1999, NF-Y binding to twin CCAAT boxes: role of Q-rich domains and histone fold helices, J. Mol. Biol., 285, 1441, 10.1006/jmbi.1998.2384 · doi:10.1006/jmbi.1998.2384
  96. Rinne, 2007, p63-associated disorders, Cell Cycle, 6, 262, 10.4161/cc.6.3.3796 · DOI · Paper page
  97. Melino, 2011, p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53, Cell Death Differ., 18, 1487, 10.1038/cdd.2011.81 · DOI · Paper page
  98. Benatti, 2008, A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response, Nucleic Acids Res., 36, 1415, 10.1093/nar/gkm1046 · DOI · Paper page
  99. Gomes, 2010, Differential regulation of p53 target genes: it's (core promoter) elementary, Genes Dev., 24, 111, 10.1101/gad.1893610 · DOI
  100. Mantovani, 1992, Monoclonal antibodies to NF-Y define its function in MHC class II and albumin gene transcription, EMBO J., 11, 3315, 10.1002/j.1460-2075.1992.tb05410.x · DOI · Paper page
  101. Lecona, 2008, Upregulation of annexin A1 expression by butyrate in human colon adenocarcinoma cells: role of p53, NF-Y, and p38 mitogen-activated protein kinase, Mol. Cell. Biol., 28, 4665, 10.1128/MCB.00650-07 · DOI · Paper page
  102. Hughes, 2010, NF-Y is essential for expression of the proapoptotic bim gene in sympathetic neurons, Cell Death Differ., 18, 937, 10.1038/cdd.2010.166 · DOI
  103. Huang, 2010, Phospho-DeltaNp63alpha/NF-Y protein complex transcriptionally regulates DDIT3 expression in squamous cell carcinoma cells upon cisplatin exposure, Cell Cycle, 9, 328, 10.4161/cc.9.2.10432 · DOI
  104. Bhattacharya, 2003, The B subunit of the CCAAT box binding transcription factor complex (CBF/NF-Y) is essential for early mouse development and cell proliferation, Cancer Res., 63, 8167
  105. Benatti, 2011, Specific inhibition of NF-Y subunits triggers different cell proliferation defects, Nucleic Acids Res., 39, 5356, 10.1093/nar/gkr128 · DOI
  106. Hung, 2011, Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters, Nat. Genet., 43, 621, 10.1038/ng.848 · DOI · Paper page
  107. Gurtner, 2010, Transcription factor NF-Y induces apoptosis in cells expressing wild-type p53 through E2F1 upregulation and p53 activation, Cancer Res., 70, 9711, 10.1158/0008-5472.CAN-10-0721 · DOI
  108. Mahmoudi, 2009, Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage, Mol. Cell, 33, 462, 10.1016/j.molcel.2009.01.028 · DOI · Paper page
  109. Mahmoudi, 2011, WRAP53 promotes cancer cell survival and is a potential target for cancer therapy, Cell Death Differ., 2, e114, 10.1038/cddis.2010.90 · DOI
  110. Ceribelli, 2009, NF-YC complexity is generated by dual promoters and alternative splicing, J. Biol. Chem., 284, 34189, 10.1074/jbc.M109.008417 · DOI
  111. Romano, 2006, Defining the regulatory elements in the proximal promoter of DeltaNp63 in keratinocytes: potential roles for Sp1/Sp3, NF-Y, and p63, J. Invest. Dermatol., 126, 1469, 10.1038/sj.jid.5700297 · DOI
  112. Hainaut, 1998, IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools, Nucleic Acids Res., 26, 205, 10.1093/nar/26.1.205 · DOI · Paper page
  113. Sigal, 2000, Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome, Cancer Res., 60, 6788
  114. Gurtner, 2010, Mutant p53-induced up-regulation of mitogen-activated protein kinase kinase 3 contributes to gain of function, J. Biol. Chem., 285, 14160, 10.1074/jbc.M109.094813 · DOI · Paper page
  115. Goodarzi, 2009, Revealing global regulatory perturbations across human cancers, Mol. Cell, 36, 900, 10.1016/j.molcel.2009.11.016 · DOI · Paper page
  116. Strano, 2002, Physical interaction with human tumor-derived p53 mutants inhibits p63 activities, J. Biol. Chem., 277, 18817, 10.1074/jbc.M201405200 · DOI · Paper page
  117. Liu, 2011, TopBP1 mediates mutant p53 gain of function through NF-Y and p63/p73, Mol Cell Biol., 22, 4464, 10.1128/MCB.05574-11 · DOI · Paper page
  118. Wright, 2006, TopBP1 contains a transcriptional activation domain suppressed by two adjacent BRCT domains, Biochem. J., 400, 573, 10.1042/BJ20060831 · DOI

Cited by

Metadata

Authors
Imbriano, C., Gnesutta, N., & Mantovani, R.
Venue
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Publisher
Elsevier BV
Published
2012-04
Volume
1825
Issue
2
Pages
131-139
ISSN
0304-419X (ISSN-L)
OpenAlex
W2064715144
Cited by
38
References
18
FWCI
2.07
Type
journal article
Language
en
Open access
green
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.